US Stock MarketDetailed Quotes
GNTA Genenta Science
- 3.225
- -0.065-1.98%
Close Jun 18 16:00 ET
58.75MMarket Cap-4694P/E (TTM)
3.300High3.225Low1.81KVolume3.300Open3.290Pre Close5.96KTurnover0.02%Turnover RatioLossP/E (Static)18.22MShares6.39052wk High2.68P/B35.91MFloat Cap2.20052wk Low--Dividend TTM11.14MShs Float13.130Historical High--Div YieldTTM2.28%Amplitude2.200Historical Low3.294Avg Price1Lot Size
About Genenta Science Company
Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.
Company Profile
SymbolGNTA
Company NameGenenta Science
Listing DateDec 15, 2021
Issue Price11.50
Founded2014
CEOMr. Pierluigi Paracchi
MarketNASDAQ
Employees14
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressVia Olgettina No. 58
CityMilan
ProvinceMilan
CountryItaly
Zip Code20132
Phone39-02-2643-4681
Websitehttp://www.genenta.com
Company Executives
- Name
- Position
- Salary
- Pierluigi Paracchi
- Chief Executive Officer, Vice Chairman of the Board and General Manager
- --
- Richard B. Slansky
- Chief Financial Officer
- --
- Dr. Carlo Russo, M.D.
- Chief Medical Officer and Head of Development
- --
- Dr. Stefania Mazzoleni, PhD
- Scientific Project Manager and Communications Officer
- --
- Dr. Mark Alan Sirgo, PhD
- Chairman of the Board
- --
- Barbara Regonini
- Finance Director
- --
- Guido Angelo Giovanni Guidi
- Independent Director
- --
- Anthony S. Marucci
- Independent Director
- --
- Roger Abravanel
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg